The way I see this is simple:
Current share price doesn't reflect the current development of science we own. Many valuations are saying $31.00+
If you add another rare disease to the mix, this valuation will increase the new valuation.
If you add in 3 more positive breakthroughs, the share valuation would be in excess of $100.00.
So, if the current share price is $22.57, there is certainly only extreme upside. We are trading in profit, we expect these profits to grow exponentially and with new disease being treated, the current share price has a very long way to go, to get to a point of stabilisation.
For me, it's one of the most simple stock picks around to generate further profits.
xoxo
Merry Christmas all.
The way I see this is simple: Current share price doesn't...
-
- There are more pages in this discussion • 42 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.00 |
Change
0.090(0.45%) |
Mkt cap ! $2.556B | |||
| Open | High | Low | Value | Volume |
| $19.88 | $20.07 | $19.73 | $11.80M | 591.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 5901 | $19.97 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.00 | 3262 | 5 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| NEU (ASX) Chart |